Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of melatonin as an adjunct in the treatment of acute mania
IRCT201705181556N98Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- May 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of melatonin in bipolar disorder (BD), sponsored by Tehran University of Medical Sciences. Started May 2017; status: completed.
02
Drugs
melatonin
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on IRCT201705181556N98.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201705181556N98.